MINItrace Magni is an automated, self-shielded cyclotron developed for in-house radioisotope manufacturing.

GE HealthCare (Nasdaq: GEHC) today announced that its MINItrace Magni cyclotron has achieved CE Mark and that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for ...

Both stocks are in negative territory this year, but upcoming earnings reports could change how investors view their ...

GE HealthCare claimed European approval for a compact cyclotron designed for the local production of rapidly decaying PET ...

Oct 5 (Reuters) - Medical device maker GE HealthCare said on Monday it would buy privately held Sofie Biosciences for $945 million in cash, in a move that strengthens its ability to manufacture and ...

The deal expands GE HealthCare’s footprint in radiopharmaceuticals, its fastest-growing segment.

GE HealthCare Technologies Inc. closed 21.63% below its 52-week high of $89.77, which the company reached on January 8th. Supported by world-class markets data from Dow Jones and FactSet, and ...

The cash deal to acquire the PET radiopharmaceuticals CMO from Trilantic North America is expected to close in H1 2027.

GE HealthCare (Nasdaq: GEHC) today announced the publication of research conducted at the University of Michigan iv ...

Add Yahoo as a preferred source to see more of our stories on Google. The solution will leverage predictive analytics and AI to recommend actions. Credit: raker / Shutterstock.com. GE HealthCare has ...

Catholic Health, a New York-based healthcare system, on Thursday announced a 10-year partnership worth approximately $500M with GE HealthCare (GEHC) to modernize its operations in the areas of imaging ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GE HealthCare Technologies is in talks over a $1bn deal to buy a private equity-backed company specialising in ...